S. 2062
Introduced in Senate · July 3, 2025June 12, 2025
Mr. Peters (for himself, Mrs. Blackburn, Mr. Budd, and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Rolling Active Pharmaceutical Ingredient and Drug Reserve Act” or the “RAPID Reserve Act”.